FindTrial
Sign In

A clinical study about the prognostic value of cardiac myosin binding protein C in acute myocardial infarction

A clinical study about the prognostic value of cardiac myosin binding protein C in acute myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069171
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

AMI Group:none

Sponsors

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years with acute chest discomfort; 2. Symptom onset or acute exacerbation time = 12 hours.

Exclusion criteria

Exclusion criteria: 1. Patients with normal cTnI level were not excluded from AMI; 2. Patients who failed to retain blood samples.

Design outcomes

Primary

MeasureTime frame
Major cardiovascular events;—

Secondary

MeasureTime frame
peak level of cMyBP-C;—

Countries

China

Contacts

Public ContactZengguang Chen

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University

zengguangchen@126.com+8618306113474

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026